Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Taichi Tamura
Observed name:
T. Tamura
Institution:
Tokyo Metropolitan Komagome Hospital
Observed institution:
Tokyo Metropolitan Komagome Hospital
ORCID:
0009-0007-0472-2050
Observed ORCID:
0009-0007-0472-2050
OpenAlex ID:
A5036639777
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis
2022
·
Taiki Hakozaki
, Alexis Nolin-Lapalme
, et al.
·
Cancers
·
52
PDF
Selection bias due to delayed comprehensive genomic profiling in Japan
2022
·
Taichi Tamura
, Masachika Ikegami
, et al.
·
Cancer Science
·
27
PDF
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Annals of Hematology
·
11
Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Cancer Medicine
·
9
PDF
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
2022
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
BMC Cancer
·
9
PDF
Bone marrow metastasis of glioblastoma multiforme mimicking acute myeloid leukemia
2020
·
Akihito Nagata
, Yusuke Kanemasa
, et al.
·
Oxford Medical Case Reports
·
7
PDF
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
2022
·
Yuka Morita
, Yusuke Kanemasa
, et al.
·
Medicine
·
5
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
2022
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
PubMed
·
4
Hemoglobin‐platelet index as a prognostic factor in patients with peripheral T‐cell lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
eJHaem
·
3
PDF
Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report
2024
·
Taichi Tamura
, Yusuke Kanemasa
, et al.
·
International Cancer Conference Journal
·
2
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
2024
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
2
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report
2021
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
Medicine
·
2
A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression
2026
·
Ai Takahara
, Yu Yagi
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
1
PDF
Site‐ and Stage‐Adapted Treatment Strategies for Gastrointestinal Diffuse Large B‐Cell Lymphoma
2025
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
European Journal Of Haematology
·
1
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
2023
·
Yuka Morita
, Yu Yagi
, et al.
·
PubMed
·
1
P58-7 Aortitis after the use of granulocyte colony stimulating factors: A case of right lower gingival carcinoma
2021
·
Masaya Watanabe
, Yusuke Kanemasa
, et al.
·
Annals of Oncology
·
1
PDF
Supplemental Material for: Zolbetuximab plus mFOLFOX6 for CLDN18.2-Positive Advanced Gastric Cancer with Multiple Bone Metastases and Disseminated Intravascular Coagulation: A Case Report
2026
·
figshare admin karger
, Taichi Tamura
, et al.
·
Figshare
Zolbetuximab plus mFOLFOX6 for Claudin-18.2-Positive Advanced Gastric Cancer with Multiple Bone Metastases and Disseminated Intravascular Coagulation: A Case Report
2026
·
Taichi Tamura
, Yusuke Kanemasa
, et al.
·
Case Reports in Oncology
PDF
774P High MTV and low CD4/CD8 ratio before apheresis are poor prognostic factors in patients with r/r LBCL treated with CAR T-cell therapy
2024
·
M. Mino
, Y. Yagi
, et al.
·
Annals of Oncology
PDF
P1153: Utility of the Frailty Score for Predicting Prognosis and Individualizing Treatment Intensity in Elderly Patients With Diffuse Large B-cell Lymphoma
2023
·
Yu Yagi
, Yusuke Kanemasa
, et al.
·
HemaSphere
1076P Cancer cachexia associated with gut microbiota and clinical outcomes of patients with non-small cell lung cancer amenable to immunotherapy
2022
·
T. Hakozaki
, A. Nolin-Lapalme
, et al.
·
Annals of Oncology
MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
2021
·
Akihiko Kageyama
, Shinichiro Makino
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
23
Citation count:
138
H-index:
6
I10-index:
3
Year
Topic
Type